New U.S. Rule to Expand Requirements for Publication of Clinical Trials

September 16, 2016

(The Wall Street Journal) – Federal health officials will soon be requiring scientists and companies to make public more details of a broader range of medical research studies, even if the results are disappointing to the researchers or to companies sponsoring the research. A rule published Friday from the Department of Health and Human Services will expand the requirements for clinical trials’ publication to include most studies of products not yet licensed by the Food and Drug Administration.